Fitness5 months ago
Researchers Identify Potential Link Between Semaglutide and Nonarthritic Anterior Ischemic Optic Neuropathy
Patients who receive GLP-1 receptor agonist semaglutide (Ozempic; Novo Nordisk) may have an increased risk of developing nonarthritic anterior ischemic optic neuropathy (NAION), according to a...
